Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Disposal

25th Sep 2006 07:03

BTG PLC25 September 2006 BTG completes sale of RFID patent portfolio London, UK, 25 September 2006: BTG plc (LSE: BGC), the medical innovationscompany, today announces that Zebra Technologies Corporation has exercised itsoption to acquire the remainder of BTG's radio frequency identification (RFID)patent portfolio for $3.8 million gross. An additional $1.4 million is receivable in relation to the sale of these andother RFID patents on satisfaction of certain conditions. BTG has already received $5.8 million from Zebra relating to this option and thesale of the other RFID patents in the financial year ended March 2006. Louise Makin, Chief Executive Officer, said: "We are pleased with the sale ofour remaining RFID patents to Zebra. This divestment is in line with ourstrategy to exit and realise value from our non-core technology areas whilstexpanding and developing our pipeline of medical products." As previously announced, BTG also earned $5.0m gross from the sale of its WebNavonline tracking patents in the first half of the current financial year. Interimresults for the half year ending 30 September 2006 will be published on 9November 2006, when BTG will also present an update for analysts on its R&Dpipeline. Ends Contacts BTG Financial Dynamics Andy Burrows, Director of Investor Relations Ben Atwell +44 (0)20 7575 1741 +44 (0)20 7831 3113 Christine Soden, Chief Financial Officer +44 (0)20 7575 1591 About BTG BTG in-licenses, develops and commercialises pharmaceuticals and other medicaltechnologies. With a substantial and growing revenue stream of royalties andmilestone payments from out-licensed products, BTG continues to strengthen itspipeline of preclinical and clinical development programmes. Active in thefields of oncology, diseases of ageing, neuroscience, drug repositioning andmedical devices, BTG works from offices in London, Philadelphia and Osakathrough a global partner network of healthcare companies and researchorganisations. For further information, visit: www.btgplc.com. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

BTG
FTSE 100 Latest
Value8,596.35
Change99.55